Assessing myocardial viability by magnetic resonance imaging;Valoración de la viabilidad miocárdica mediante resonancia magnética

Revista Espanola de Cardiologia Suplementos

Volumn 6, Issue E, 2006, Pages

  Catalán, Paz ^a   Delgado, Victoria ^b   Moya, José Luis ^a   Pare, Carles ^b   Muñoz, María ^a   Caralt, Teresa ^b   Asín, Enrique ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Cardiovascular magnetic resonance; Ischemic heart disease; Left ventricular systolic dysfunction; Myocardial hibernation; Myocardial infarction; Myocardial viability

Indexed keywords

DOBUTAMINE; GADOLINIUM PENTETATE; RADIOACTIVE MATERIAL;

ARTICLE; CONTRAST ENHANCEMENT; ECHOCARDIOGRAPHY; EXERCISE TEST; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE CONTRACTION; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOCARDIOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING;

EID: 35948998854     PISSN: 11313587     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Braunwald E, Kloner RA. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation. 1982;66:1146-9.
2. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211-21.
3. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of funcional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: Comparison of pooled data. J Am Coll Cardiol. 1997;30:1451-60.
4. Baumgartner H, Porenta G, Lau YK, Wutte M, Klaar U, Mehrabi M, et al. Assessment of myocardial viability by dobutamine echocardiography, positron emission tomography and thallium-201 SPECT: correlation with histopathology in explanted hearts. J Am Coll Cardiol. 1998;32:1701-8.
5. 31P Magnetic Resonance Spectroscopy. Circulation. 1995;92:15-23.
6. Bottomley PA, Weiss RG. Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium. Lancet. 1998;351:714-8.
7. Judd RM, Lugo-Olivieri CH, Arai M, Kondo T, Croisille P, Lima JA, et al. Physiological basis of myocardial contrast enhancement in Fast Magnetic Resonance Images of 2-day-old reperfused canine infarcts. Circulation. 1995;92:1902-10.
8. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999;100:1992-2002.
9. Gerber BL, Rochitte CE, Bluemke DA, Melin JA, Crosille P, Becker LC, et al. Relation between Gd-DTPA contrast enhancement Catalán P et al. Valoración de la viabilidad miocárdica mediante resonancia magnética and regional inotropic response in the periphery and center of myocardial infarction. Circulation 2001;104:998-1004.
10. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445-53.
11. Hillenbrand HB, Kim RJ, Parker MA, Fieno DS, Judd RM. Early assessment of myocardial salvage by contrast-enhanced magnetic resonance imaging. Circulation. 2000;102:1678-83.
12. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001;357:21-8.
13. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374-9.
14. Klein C, Nekolla SG, Bengel FM, Momose M, Sammer A, Haas F, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation. 2002;105:162-7.
15. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001;104:1101-7.
16. Gerber BL, Garot J, Bluemke DA, Wu KC, Lima JA. Accuracy of contrast-enhanced magnetic resonance imaging in predicting improvement of regional myocardial function in patients after acute myocardial infarction. Circulation. 2002;106:1083-9.
17. 18F- fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2003;41:1341-8.
18. Beek AM, Kuhl HP, Bondarenko O, Twisk JW, Hofman MB, Van Dockum WG, et al. Delayed contrast-enhanced magnetic resonance imaging for the prediction of regional functional improvement after acute myocardial infarction. J Am Coll Cardiol. 2003;42:895-901.
19. Yokota C, Nonogi H, Miyazaki S, Goto Y, Maeno M, Daikoku S, et al. Gadolinium-enhanced magnetic resonance imaging in acute myocardial infarction. Am J Cardiol. 1995;75:577-81.
20. Dendale P, Franken PR, Block P, Pratikakis Y, De Roos A. Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction. Am Heart J. 1998;135:875-80.
21. Kramer CM, Rogers WJ Jr, Mankad S, Theobald TM, Pakstis DL, Hu YL. Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction. J Am Coll Cardiol. 2000;36:1835-40.
22. Saeed M, Lund G, Wendland MF, Bremerich J, Weinmann H, Higgins CB. Magnetic resonance characterization of the peri- infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation. 2001;103:871-6.
23. Vila M, Pujadas S, Carreras F, Noguero M, García-Moll X, Leta G, et al. Patrones evolutivos de necrosis miocárdica detectados mediante cardiorresonancia magnética por el método de realce tardío de gadolinio. Rev Esp Cardiol. 2005;58 Supl 1:118.
24. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation. 2002;105:224-9.
25. Gunning MG, Kaprielian RR, Pepper J, Pennell DJ, Sheppard MN, Severs NJ, et al. The histology of viable and hibernating myocardium in relation to imaging characteristics. J Am Coll Cardiol. 2002;39:428-35.
26. Sechtem U, Voth E, Baer F, Schneider C, Theissen P, Schicha H. Assessment of residual viability in patients with myocardial infarction using magnetic resonance techniques. Int J Card Imaging. 1993;9 Suppl 1:31-40.
27. McNamara MT, Higgins CB. Magnetic resonance imaging of chronic myocardial infarcts in man. Am J Roentgenol. 1986;146:315-20.
28. Baer FM, Smolarz K, Jungehulsing M, Beckwilm J, Theissen P, Sechtem U, et al. Chronic myocardial infarction, assessment of morphology, function and perfusion by gradient magnetic resonance imaging and 99mTC-Methoxyisobutyl- Isonitrile SPECT. Am Heart J. 1992;123:636-45.
29. 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction. Circulation. 1992;86:1125-37.
30. Lawson MA, Johnson LL, Coghlan L, Alami M, Tauxe EL, Reinert SE, et al. Correlation of Thallium uptake with left ventricular wall thickness by cine magnetic resonance imaging in patients with acute and healed myocardial infarcts. Am J Cardiol. 1997;80:434-41.
31. Baer FM, Theissen P, Schneider CA, Voth E, Sechtem U, Schicha H, et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol. 1998;31:1040-8.
32. Lauerma K, Niemi P, Hanninen H, Janatuinen T, Voipio-Pulkki LM, Knuuti J, et al. Multimodality MR imaging assessment of myocardial viability: combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG-PET-initial experience. Radiology. 2000;217:729-36.
33. Kim WY, Danias PG, Stuber M, Flamm SD, Plein S, Nagel E, et al. Coronary magnetic resonance angiography for the detection of coronary stenosis. N Engl J Med. 2001;345:1863-9.
34. Jiménez Borreguero LJ, Maté I, Pereira J, Mateos M, Dago J, Sánchez J. Assessment of patency of aortocoronary grafts by magnetic resonance in Cabrol's operation of aorta. J Cardiovasc Magn Reson. 1998;1:75.
35. Jahnke C, Paetsch I, Nehrke K, Schnackenburg B, Gebker R, Fleck E, et al. Rapid and complete coronary arterial tree visualization with magnetic resonance imaging: feasibility and diagnostic performance. Eur Heart J. 2005;26:2313-9.
36. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation. 2002;105:656-62.
37. Rogers WJ Jr, Kramer CM, Geskin G, Hu YL, Theobald TM, Vido DA, et al. Early contrast enhanced MRI predicts late functional recovery after reperfused myocardial infarction. Circulation. 1999;99:744-50.
38. Wu KC, Kim RJ, Bluemke DA, Rochitte CE, Zerhouni EA, Becker LC, et al. Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion. J Am Coll Cardiol. 1998;32:1756-64.
39. Gerber BL, Rochitte CE, Melin JA, McVeigh ER, Bluemke DA, Wu KC, et al. Microvascular obstruction and left ventricular remodeling early after acute myocardial infarction. Circulation. 2000;101:2734-41.
40. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical implications of the «no reflow» phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation. 1996;93:223-8.
41. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, et al. The prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765-72.
42. Schwaiger M. Contrast-enhanced magnetic resonance imaging effectively assesses myocardial viability. Evidence-based Cardiovascular Medicine. 2002;2:91-2.
43. López-Lereu MP, Bodí V, Sanchís J, García D, Pellicer M, Losada A, et al. Fiabilidad de los índices de viabilidad miocárdica por resonancia magnética para predecir la mejoría de la función sistólica en pacientes con un primer infarto reciente y arteria abierta. Rev Esp Cardiol. 2004;57:826-33.
44. Ichikawa, Y, Sakuma, H, Suzawa, N, Kitagawa K, Makino K, Hirano T, et al. Late gadolinium-enhanced magnetic resonance imaging in acute and chronic myocardial infarction: improved prediction of regional myocardial contraction in the chronic state by measuring thickness of nonenhanced myocardium. J Am Coll Cardiol. 2005;45:901-9.
45. Wellnhofer E, Olariu A, Klein C, Grafe M, Wahl A, Fleck E, et al. Magnetic resonance low-dose dobutamina test is superior to scar quantification for the prediction of functional recovery. Circulation. 2004;109:2172-4.
46. Van Hoe L, Vanderheyden M. Ischemic cardiomyopathy: value of different MRI techniques for prediction of functional recovery after revascularization. Am J Roentgenol. 2004;182:95-100.
47. Shah DP, Kim HW, Elliot M, Wu E, Shah BB, Thomson LEJ, et al. Contrast MRI predicts reverse remodeling and contractile improvement in akinetic thinned myocardium. J Cardiovasc Magn Reson. 2004;6:66.